AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Investor Presentation • Oct 22, 2020

3662_rns_2020-10-22_fa241e38-0308-4400-800e-66c6370dae48.html

Investor Presentation

Open in Viewer

Opens in native device viewer

Presentation of third quarter results 2020 for Medistim ASA

Sales for the quarter ended at MNOK 83.4 (MNOK 85.5), a decrease of 2.5%. Sales as of September ended at MNOK 268.9 (MNOK 268.1). Sales in the US increased with 16.6 % in NOK. Currency neutral growth was 6.5%. Operating result (EBIT) for the quarter ended at MNOK 20.8 (MNOK 19.2) an 8.7% increase. Operating result year to date September ended at MNOK 73.3 (MNOK 70.0), a 4.8% increase. This is the best operating result for the first three quarters ever. Cashflow from operations was a solid MNOK 54.4. Cash by the end of the quarter was MNOK 114.9. The Board has decided to pay out, as previously proposed, the 2019 dividend of NOK 2.75 per share.